调节内质网膜应激减弱了巨细胞脱粒的作用
Jialiang Fan1, Longpeng Ma1, Bailing Xie2
1Department of Pediatric Otolaryngology, Shenzhen Hospital, and Third School of Clinical Medicine, Southern Medical University, Shenzhen, China; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen, China; Institute of Allergy & Immunology, Shenzhen University School of Medicine, State Key Laboratory of Respiratory Disease Shenzhen University Division, Shenzhen, China.
细胞内膜网膜 (ER) 的压力驱动着巨细胞脱粒化和过敏症状. 抑制X-box-1结合蛋白 (XBP1) 途径抑制了这种脱粒,为过敏性鼻炎提供了潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 乳腺细胞降粒是过敏反应的关键因素.
- 细胞内膜网膜 (ER) 的压力与过敏性疾病的发病有关.
- 巨细胞脱粒的精确机制需要进一步阐明.
研究的目的:
- 为了研究ER应激在巨细胞脱粒化中的作用.
- 为了确定将ER压力与巨细胞介质释放联系起来的分子通路.
主要方法:
- 使用骨髓衍生和气道隔离的乳腺细胞.
- 评估了ER应激调节对质细胞介质释放的影响.
- 采用RNA测序 (RNAseq) 来分析杆细胞基因表达.
主要成果:
- 研究人员发现,乳腺细胞敏感化会增加ER的压力.
- 结合X-box-1结合蛋白 (XBP1) 的活性与巨细胞脱粒化相关.
- 调节ER压力或XBP1受影响的杆细胞介质释放.
- 腺氨酸激酶 (Syk) 的XBP1激活促进了中间体的释放.
- 赛马福林3A抑制了巨细胞媒介释放,减轻了实验性过敏性鼻炎 (AR).
结论:
- ER压力与巨细胞脱粒化有显著的联系.
- 抑制XBP1,一个关键的ER压力分子,有效地抑制巨细胞脱粒化.
- 针对ER应激通路,特别是XBP1,为管理过敏性鼻炎提供了一个可行的策略.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
GPCR Desensitization
The Unfolded Protein Response
Inflammation
Role of Matrix Metalloproteases in Degradation of ECM
Regulation of the Unfolded Protein Response


